HealthStream (HSTM) Competitors

HealthStream (NASDAQ:HSTM) and Omnicell (NASDAQ:OMCL) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, community ranking, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

Does the MarketBeat Community prefer HSTM or OMCL?

Omnicell received 38 more outperform votes than HealthStream when rated by MarketBeat users. Likewise, 66.93% of users gave Omnicell an outperform vote while only 66.57% of users gave HealthStream an outperform vote.

Company	Underperform	Outperform
HealthStream	Outperform Votes 462 66.57%	Underperform Votes 232 33.43%
Omnicell	Outperform Votes 500 66.93%	Underperform Votes 247 33.07%

Do analysts rate HSTM or OMCL?

HealthStream currently has a consensus target price of $31.50, suggesting a potential downside of 4.20%. Omnicell has a consensus target price of $52.33, suggesting a potential upside of 31.76%. Given Omnicell's higher probable upside, analysts clearly believe Omnicell is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthStream	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75
Omnicell	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Do insiders and institutionals hold more shares of HSTM or OMCL?

69.6% of HealthStream shares are owned by institutional investors. Comparatively, 97.7% of Omnicell shares are owned by institutional investors. 20.6% of HealthStream shares are owned by insiders. Comparatively, 2.6% of Omnicell shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Does the media prefer HSTM or OMCL?

In the previous week, Omnicell had 1 more articles in the media than HealthStream. MarketBeat recorded 8 mentions for Omnicell and 7 mentions for HealthStream. Omnicell's average media sentiment score of 0.93 beat HealthStream's score of 0.90 indicating that Omnicell is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthStream	5 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Omnicell	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is HSTM or OMCL more profitable?

HealthStream has a net margin of 6.84% compared to Omnicell's net margin of 1.13%. HealthStream's return on equity of 5.67% beat Omnicell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthStream	6.84%	5.67%	3.91%
Omnicell	1.13%	3.82%	2.07%

Which has more risk & volatility, HSTM or OMCL?

HealthStream has a beta of 0.39, suggesting that its share price is 61% less volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.78, suggesting that its share price is 22% less volatile than the S&P 500.

Which has better earnings and valuation, HSTM or OMCL?

HealthStream has higher earnings, but lower revenue than Omnicell. HealthStream is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthStream	$279.06M	3.58	$15.21M	$0.65	50.59
Omnicell	$1.11B	1.65	$12.53M	$0.27	147.12

Summary

Omnicell beats HealthStream on 10 of the 19 factors compared between the two stocks.